Gilead Sciences to Present at Two Upcoming Investor Conferences
May 31 2011 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the Goldman Sachs Healthcare
Conference in Rancho Palos Verdes, California and the Jefferies
Global Healthcare Conference in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, will provide an overview of the company at the Goldman
Sachs conference on Tuesday, June 7 at 11:20 a.m. Pacific Daylight
Time (2:20 p.m. Eastern Daylight Time (EDT)).
Kevin Young, Gilead’s Executive Vice President, Commercial
Operations, will provide an overview of the company at the
Jefferies conference on Wednesday, June 8 at 1:30 p.m. EDT.
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please
visit www.gilead.com orcall the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024